Coloplast
699.8
DKK
-1.05 %
Less than 1K followers
COLO B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-1.05%
-8.4%
-10.65%
-10.99%
-20.11%
-23.9%
-32.29%
-29.67%
+1,392.11%
Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Read moreMarket cap
159.69B DKK
Turnover
26.98M DKK
Revenue
27.03B
EBIT %
27.08 %
P/E
31.16
Dividend yield-%
3.14 %
Financial calendar
6.4
2025
Interim report Q2'25
19.8
2025
Interim report Q3'25
4.11
2025
Annual report '25
All
Research
Press releases
ShowingAll content types
Coloplast A/S - Allocation of Share Options
Coloplast A/S - Interim Financial Report, Q1 2024/25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Coloplast A/S - Regnskabsmeddelelse, Q1 2024/25
Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET (correction)
Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET
